Answer Questions About COVID-19 Vaccines in Young Children
September 2022
You’ll be asked about vaccinating young kids against COVID-19 now that Moderna’s Spikevax is the first approved down to age 6 months.
Preliminary evidence suggests Spikevax is about 50% effective in kids age 6 to 23 months and 37% in those age 2 to 5 years at preventing symptomatic COVID-19...with similar side effects as in older children.
Point out that the study in this youngest age group was done when Omicron was already highly circulating...so it’s not surprising that vaccine efficacy is lower than earlier studies in older children.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive